Search

Your search keyword '"Maass, Alexander H."' showing total 608 results
Start Over Author "Maass, Alexander H."
608 results on '"Maass, Alexander H."'

5. Predictive value of the PRAETORIAN score for defibrillation test success in patients with subcutaneous ICD: A subanalysis of the PRAETORIAN-DFT trial

Author

Knops, Reinoud E., El-Chami, Mikhael F., Marquie, Christelle, Nordbeck, Peter, Quast, Anne-Floor B.E., Tilz, Roland R., Brouwer, Tom F., Lambiase, Pier D., Cassidy, Christopher J., Boersma, Lucas V.A., Burke, Martin C., Pepplinkhuizen, Shari, de Veld, Jolien A., de Weger, Anouk, Bracke, Frank A.L.E., Manyam, Harish, Probst, Vincent, Betts, Timothy R., Bijsterveld, Nick R., Defaye, Pascal, Demming, Thomas, Elders, Jan, Field, Duncan C., Ghani, Abdul, Golovchiner, Gregory, de Jong, Jonas S.S.G., Lewis, Nigel, Marijon, Eloi, Martin, Claire A., Miller, Marc A., Shaik, Naushad A., van der Stuijt, Willeke, Kuschyk, Jürgen, Olde Nordkamp, Louise R.A., Arya, Anita, Borger van der Burg, Alida E., Boveda, Serge, van Doorn, Dirk J., Glikson, Michael, Kaiser, Lukas, Maass, Alexander H., van Woerkens, Léon J.P.M., Zaidi, Amir, Wilde, Arthur A.M., and Smeding, Lonneke

Published
2024
Full Text
View/download PDF

9. Clinical Decision Making and Technical Approaches in Implantable Cardioverter-Defibrillator Procedures: A Step by Step Critical Appraisal of Literature.

Author

Roseboom, Eva, Smit, Marcelle D., Groenveld, Hessel F., Rienstra, Michiel, and Maass, Alexander H.

Abstract

The selection of an appropriate implantable cardioverter-defibrillator (ICD) type and implantation strategy involves a myriad of considerations. While transvenous ICDs are standard, the rise of non-transvenous options like subcutaneous ICDs and extravascular ICDs is notable for their lower complication rates. Historical preferences for dual chamber ICDs have shifted to single-chamber ICDs. Singlecoil ICDs are preferred for easier extraction, and the use of the DF-4 connector is generally recommended. Cephalic cutdown is the preferred venous access technique, while axillary vein puncture is a viable alternative. The right ventricular apex remains the preferred lead position until further evidence on conduction system pacing emerges. Left-sided, subcutaneous ICD implantation is considered reliable, contingent on specific cases. A meticulous perioperative plan, including antibiotic prophylaxis and an antithrombotic regimen, is crucial for successful implantation. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

10. Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter‐Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO‐IT)) Registry

Author

van Veelen, Anna, primary, Verstraelen, Tom E., additional, Somsen, Yvemarie B. O., additional, Elias, Joëlle, additional, van Dongen, Ivo M., additional, Delnoy, Peter Paul H. M., additional, Scholten, Marcoen F., additional, Boersma, Lucas V. A., additional, Maass, Alexander H., additional, Strikwerda, Sipke, additional, Firouzi, Mehran, additional, Allaart, Cornelis P., additional, Vernooy, Kevin, additional, Grauss, Robert W., additional, Tukkie, Raymond, additional, Knaapen, Paul, additional, Zwinderman, Aeilko H., additional, Dijkgraaf, Marcel G. W., additional, Claessen, Bimmer E. P. M., additional, van Barreveld, Marit, additional, Wilde, Arthur A. M., additional, Henriques, José P. S., additional, van Gent, M. W. F., additional, Bouwels, L. H. R., additional, van der Voort, P. H., additional, Theuns, D. A. M. J., additional, Bijsterveld, N. R., additional, Abels, R., additional, van Erven, L., additional, Takens, L. H., additional, Kimman, G. P., additional, van der Burg, A. E. Borger, additional, Khan, M., additional, Derksen, R., additional, Vet, M. W., additional, Widdershoven, J. W. M. G., additional, Brouwer, M. A., additional, Meine, M., additional, Tuinenburg, A. E., additional, and Spierenburg, H. A. M., additional

Published
2024
Full Text
View/download PDF

14. Trends in adoption of extravascular cardiac implantable electronic devices:the Dutch cohort

Author

Breeman, Karel T. N., Knops, Reinoud E., van der Stoel, Michelle D., Boersma, Lucas V. A., Yap, Sing-Chien, van Erven, Lieselot, van Dijk, Vincent F., Maass, Alexander H., Wilde, Arthur A. M., Tjong, Fleur V. Y., Breeman, Karel T. N., Knops, Reinoud E., van der Stoel, Michelle D., Boersma, Lucas V. A., Yap, Sing-Chien, van Erven, Lieselot, van Dijk, Vincent F., Maass, Alexander H., Wilde, Arthur A. M., and Tjong, Fleur V. Y.

Abstract

Introduction: Conventional implantable cardioverter-defibrillators (ICDs) and pacemakers carry a risk of pocket- and lead-related complications in particular. To avoid these complications, extravascular devices (EVDs) have been developed, such as the subcutaneous ICD (S-ICD) and leadless pacemaker (LP). However, data on patient or centre characteristics related to the actual adoption of EVDs are lacking. Objective: To assess real-world nationwide trends in EVD adoption in the Netherlands. Methods: Using the Netherlands Heart Registration, all consecutive patients with a de novo S‑ICD or conventional single-chamber ICD implantation between 2012–2020, or de novo LP or conventional single-chamber pacemaker implantation between 2014–2020 were included. Trends in adoption are described for various patient and centre characteristics. Result: From 2012–2020, 2190 S‑ICDs and 10,683 conventional ICDs were implanted; from 2014–2020, 712 LPs and 11,103 conventional pacemakers were implanted. The general use has increased (S-ICDs 8 to 21%; LPs 1 to 8%), but this increase seems to have reached a plateau. S‑ICD recipients were younger than conventional ICD recipients (p < 0.001) and more often female (p < 0.001); LP recipients were younger than conventional pacemaker recipients (p < 0.001) and more often male (p = 0.03). Both S‑ICDs and LPs were mainly implanted in high-volume centres with cardiothoracic surgery on-site, although over time S‑ICDs were increasingly implanted in centres without cardiothoracic surgery (p < 0.001). Conclusion: This nationwide study demonstrated a relatively quick adoption of innovative EVDs with a plateau after approximately 4 years. S‑ICD use is especially high in younger patients. EVDs are mainly implanted in high-volume centres with cardiothoracic surgery back-up, but S‑ICD use is expanding beyond those centres.

Published
2024

15. Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients:a position statement by the Task Force of the Dutch Society of Cardiology

Author

van der Lingen, Anne Lotte C.J., Verstraelen, Tom E., van Erven, Lieselot, Meeder, Joan G., Theuns, Dominic A., Vernooy, Kevin, Wilde, Arthur A.M., Maass, Alexander H., Allaart, Cornelis P., van der Lingen, Anne Lotte C.J., Verstraelen, Tom E., van Erven, Lieselot, Meeder, Joan G., Theuns, Dominic A., Vernooy, Kevin, Wilde, Arthur A.M., Maass, Alexander H., and Allaart, Cornelis P.

Abstract

International guidelines recommend implantation of an implantable cardioverter-defibrillator (ICD) in non-ischaemic cardiomyopathy (NICM) patients with a left ventricular ejection fraction (LVEF) below 35% despite optimal medical therapy and a life expectancy of more than 1 year with good functional status. We propose refinement of these recommendations in patients with NICM, with careful consideration of additional risk parameters for both arrhythmic and non-arrhythmic death. These additional parameters include late gadolinium enhancement on cardiac magnetic resonance imaging and genetic testing for high-risk genetic variants to further assess arrhythmic risk, and age, comorbidities and sex for assessment of non-arrhythmic mortality risk. Moreover, several risk modifiers should be taken into account, such as concomitant arrhythmias that may affect LVEF (atrial fibrillation, premature ventricular beats) and resynchronisation therapy. Even though currently no valid cut-off values have been established, the proposed approach provides a more careful consideration of risks that may result in withholding ICD implantation in patients with low arrhythmic risk and substantial non-arrhythmic mortality risk.

Published
2024

32. Association of vectorcardiographic T-wave area with clinical and echocardiographic outcomes in cardiac resynchronization therapy.

Author

Dural, Muhammet, Ghossein, Mohammed A, Gerrits, Willem, Daniels, Fenna, Meine, Mathias, Maass, Alexander H, Rienstra, Michiel, Prinzen, Frits W, Vernooy, Kevin, and Stipdonk, Antonius M W van

Abstract

Aims Data on repolarization parameters in cardiac resynchronization therapy (CRT) are scarce. We investigated the association of baseline T-wave area, with both clinical and echocardiographic outcomes of CRT in a large, multi-centre cohort of CRT recipients. Also, we evaluated the association between the baseline T-wave area and QRS area. Methods and results In this retrospective study, 1355 consecutive CRT recipients were evaluated. Pre-implantation T-wave and QRS area were calculated from vectorcardiograms. Echocardiographic response was defined as a reduction of ≥15% in left ventricular end-systolic volume between 3 and 12 months after implantation. The clinical outcome was a combination of all-cause mortality, heart transplantation, and left ventricular assist device implantation. Left ventricular end-systolic volume reduction was largest in patients with QRS area ≥ 109 μVs and T-wave area ≥ 66 μVs compared with QRS area ≥ 109 μVs and T-wave area < 66 μVs (P = 0.004), QRS area < 109 μVs and T-wave area ≥ 66 μVs (P < 0.001) and QRS area < 109 μVs and T-wave area < 66 μVs (P < 0.001). Event-free survival rate was higher in the subgroup of patients with QRS area ≥ 109 μVs and T-wave area ≥ 66 μVs (n = 616, P < 0.001) and QRS area ≥ 109 μVs and T-wave area < 66 μVs (n = 100, P < 0.001) than the other subgroups. In the multivariate analysis, T-wave area remained associated with echocardiographic response (P = 0.008), but not with the clinical outcome (P = 0.143), when QRS area was included in the model. Conclusion Baseline T-wave area has a significant association with both clinical and echocardiographic outcomes after CRT. The association of T-wave area with echocardiographic response is independent from QRS area; the association with clinical outcome, however, is not. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

33. Comparison of strain imaging techniques in CRT candidates: CMR tagging, CMR feature tracking and speckle tracking echocardiography

Author

van Everdingen, Wouter M., Zweerink, Alwin, Nijveldt, Robin, Salden, Odette A. E., Meine, Mathias, Maass, Alexander H., Vernooy, Kevin, De Lange, Frederik J., van Rossum, Albert C., Croisille, Pierre, Clarysse, Patrick, Geelhoed, Bastiaan, Rienstra, Michiel, Van Gelder, Isabelle C., Vos, Marc A., Allaart, Cornelis P., and Cramer, Maarten J.

Published
2018
Full Text
View/download PDF

35. Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders

Author

Gorter, Thomas M., primary, van Veldhuisen, Dirk J., additional, Mulder, Bart A., additional, Artola Arita, Vicente A., additional, van Empel, Vanessa P. M., additional, Manintveld, Olivier C., additional, Tieleman, Robert G., additional, Maass, Alexander H., additional, Vernooy, Kevin, additional, van Gelder, Isabelle C., additional, and Rienstra, Michiel, additional

Published
2023
Full Text
View/download PDF

38. PO-02-084 3-MONTH MAJOR COMPLICATION RATE OF EXTRAVASCULAR DEVICES COMPARED TO CONVENTIONAL TRANSVENOUS DEVICES: REAL-WORLD DATA FROM THE NETHERLANDS HEART REGISTRATION

Author

Breeman, Karel, primary, van der Stoel, Michelle D., additional, van Dijk, Vincent, additional, Yap, Sing-Chien, additional, Van Erven, Lieselotte, additional, Maass, Alexander H., additional, Boersma, Lucas V., additional, Wilde, Arthur A., additional, Knops, Reinoud, additional, and Tjong, Fleur V., additional

Published
2023
Full Text
View/download PDF

39. LB-456087-1 FIRST RESULTS OF THE RANDOMIZED PRAETORIAN-DFT TRIAL: PROSPECTIVE VALIDATION OF THE PRAETORIAN SCORE FOR PREDICTION OF DEFIBRILLATION TEST SUCCESS AFTER SUBCUTANEOUS ICD IMPLANT

Author

Knops, Reinoud, primary, Pepplinkhuizen, Shari, additional, El-Chami, Mikhael F., additional, Marquie, Christelle, additional, Nordbeck, Peter, additional, Tilz, Roland R., additional, Lambiase, Pier D., additional, Quast, Anne-Floor B., additional, Brouwer, Tom F., additional, Cassidy, Christopher J., additional, Boersma, Lucas V., additional, Betts, Timothy R., additional, Delnoy, Peter Paul, additional, Bonnemeier, Hendrik, additional, Burke, Martin C., additional, Bracke, Frank A., additional, Probst, Vincent, additional, Manyam, Harish, additional, Miller, Marc A., additional, Kuschyk, Jurgen, additional, de Weger, Anouk, additional, De Jong, Jonas, additional, Lewis, Nigel T., additional, Marijon, Eloi, additional, Bijsterveld, Nick, additional, Defaye, Pascal, additional, Martin, Claire A., additional, Field, Duncan C., additional, Golovchiner, Gregory, additional, Elders, Jan, additional, Shaik, Naushad A., additional, Boveda, Serge, additional, van der Stuijt, Willeke, additional, de Veld, Jolien A., additional, Kaiser, Lukas, additional, Arya, Anita, additional, Jan van Doorn, Dirk, additional, Van Woerkens, Leon, additional, Borger Van Der Burg, Alida E., additional, Glikson, Michael, additional, Maass, Alexander H., additional, Zaidi, Amir M., additional, Nemirovsky, Dmitry, additional, Wilde, Arthur A., additional, and Smeding, Lonneke Schats, additional

Published
2023
Full Text
View/download PDF

40. Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction:(Additive) Value of Implantable Loop Recorders

Author

Gorter, Thomas M., van Veldhuisen, Dirk J., Mulder, Bart A., Artola Arita, Vicente A., van Empel, Vanessa P.M., Manintveld, Olivier C., Tieleman, Robert G., Maass, Alexander H., Vernooy, Kevin, van Gelder, Isabelle C., Rienstra, Michiel, Gorter, Thomas M., van Veldhuisen, Dirk J., Mulder, Bart A., Artola Arita, Vicente A., van Empel, Vanessa P.M., Manintveld, Olivier C., Tieleman, Robert G., Maass, Alexander H., Vernooy, Kevin, van Gelder, Isabelle C., and Rienstra, Michiel

Abstract

Background: Atrial fibrillation (AF) is common in heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and has a negative impact on outcome. Reliable data on prevalence, incidence, and detection of AF from contemporary, prospective HFmrEF/HFpEF studies are scarce. Methods: This was a prespecified sub-analysis from a prospective, multicenter study. Patients with HFmrEF/HFpEF underwent 12-lead electrocardiography (ECG), 24 h Holter monitoring, and received an implantable loop recorder (ILR) at the study start. During the 2 year follow-up, rhythm monitoring was performed via ILR, yearly ECG, and two yearly 24 h Holter monitors. Results: A total of 113 patients were included (mean age 73 ± 8 years, 75% HFpEF). At baseline, 70 patients (62%) had a diagnosis of AF: 21 paroxysmal, 18 persistent, and 31 permanent AF. At study start, 45 patients were in AF. Of the 43 patients without a history of AF, 19 developed incident AF during a median follow-up of 23 [15–25] months (44%; incidence rate 27.1 (95% confidence interval 16.3–42.4) per 100 person-years). Thus, after the 2-year follow-up, 89 patients (79%) had a diagnosis of AF. In 11/19 incident AF cases (i.e., 58%), AF was solely detected on the ILR. Yearly 12-lead ECG detected six incident AF cases and four of these cases were also detected on two yearly 24 h Holter monitors. Two incident AF cases were detected on an unplanned ECG/Holter. Conclusions: Atrial fibrillation is extremely common in heart failure with HFmrEF/HFpEF and may inform on symptom evaluation and treatment options. AF screening with an ILR had a much higher diagnostic yield than conventional modalities.

Published
2023

41. NL-EVDR:Netherlands—ExtraVascular Device Registry

Author

Tjong, Fleur V.Y., Breeman, Karel T.N., Boersma, Lucas V.A., Yap, Sing Chien, van Erven, Lieselot, van der Stoel, Michelle D., van Dijk, Vincent F., Maass, Alexander H., Knops, Reinoud E., Tjong, Fleur V.Y., Breeman, Karel T.N., Boersma, Lucas V.A., Yap, Sing Chien, van Erven, Lieselot, van der Stoel, Michelle D., van Dijk, Vincent F., Maass, Alexander H., and Knops, Reinoud E.

Abstract

Cardiac implantable electronic device (CIED) therapy is an essential element in treating cardiac arrhythmias. Despite their benefits, conventional transvenous CIEDs are associated with a significant risk of mainly pocket- and lead-related complications. To overcome these complications, extravascular devices (EVDs), such as the subcutaneous implantable cardioverter-defibrillator and intracardiac leadless pacemaker, have been developed. In the near future, several other innovative EVDs will become available. However, it is difficult to evaluate EVDs in large studies because of high costs, lack of long-term follow-up, imprecise data or selected patient populations. To improve evaluation of these technologies, real-world, large-scale, long-term data are of utmost importance. A Dutch registry-based study seems to be a unique possibility for this goal due to early involvement of Dutch hospitals in novel CIEDs and an existing quality control infrastructure, the Netherlands Heart Registration (NHR). Therefore, we will soon start the Netherlands—ExtraVascular Device Registry (NL-EVDR), a Dutch nationwide registry with long-term follow-up of EVDs. The NL-EVDR will be incorporated in NHR’s device registry. Additional EVD-specific variables will be collected both retrospectively and prospectively. Hence, combining Dutch EVD data will provide highly relevant information on safety and efficacy. As a first step, a pilot project has started in selected centres in October 2022 to optimise data collection.

Published
2023

42. Association of vectorcardiographic T-wave area with clinical and echocardiographic outcomes in cardiac resynchronization therapy

Author

Onderzoek Device, Team Medisch, Circulatory Health, Dural, Muhammet, Ghossein, Mohammed A, Gerrits, Willem, Daniels, Fenna, Meine, Mathias, Maass, Alexander H, Rienstra, Michiel, Prinzen, Frits W, Vernooy, Kevin, van Stipdonk, Antonius M W, Onderzoek Device, Team Medisch, Circulatory Health, Dural, Muhammet, Ghossein, Mohammed A, Gerrits, Willem, Daniels, Fenna, Meine, Mathias, Maass, Alexander H, Rienstra, Michiel, Prinzen, Frits W, Vernooy, Kevin, and van Stipdonk, Antonius M W

Published
2023

43. Comparison of the relation of the ESC 2021 and ESC 2013 definitions of left bundle branch block with clinical and echocardiographic outcome in cardiac resynchronization therapy

Author

Cardiologie, Onderzoek Device, Team Medisch, Circulatory Health, Rijks, Jesse, Ghossein, Mohammed A., Wouters, Philippe C., Dural, Muhammet, Maass, Alexander H., Meine, Mathias, Kloosterman, Mariëlle, Luermans, Justin, Prinzen, Frits W., Vernooy, Kevin, van Stipdonk, Antonius M.W., Cardiologie, Onderzoek Device, Team Medisch, Circulatory Health, Rijks, Jesse, Ghossein, Mohammed A., Wouters, Philippe C., Dural, Muhammet, Maass, Alexander H., Meine, Mathias, Kloosterman, Mariëlle, Luermans, Justin, Prinzen, Frits W., Vernooy, Kevin, and van Stipdonk, Antonius M.W.

Published
2023

44. Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy

Author

Electrofysiologie, Onderzoek Device, Cardiovasculaire Immunologie, Team Onderzoek, Team Medisch, Circulatory Health, Regenerative Medicine and Stem Cells, Gezonde Vaten, Wouters, Philippe C., van de Leur, Rutger R., Vessies, Melle B., van Stipdonk, Antonius M.W., Ghossein, Mohammed A., Hassink, Rutger J., Doevendans, Pieter A., van der Harst, Pim, Maass, Alexander H., Prinzen, Frits W., Vernooy, Kevin, Meine, Mathias, van Es, René, Electrofysiologie, Onderzoek Device, Cardiovasculaire Immunologie, Team Onderzoek, Team Medisch, Circulatory Health, Regenerative Medicine and Stem Cells, Gezonde Vaten, Wouters, Philippe C., van de Leur, Rutger R., Vessies, Melle B., van Stipdonk, Antonius M.W., Ghossein, Mohammed A., Hassink, Rutger J., Doevendans, Pieter A., van der Harst, Pim, Maass, Alexander H., Prinzen, Frits W., Vernooy, Kevin, Meine, Mathias, and van Es, René

Published
2023

46. Hearts in their hands—Physicians’ gestures embodying shared professional knowledge around the world

Author

Quasinowski, Benjamin, primary, Assa, Solmaz, additional, Bachmann, Cadja, additional, Chen, Wei, additional, Elcin, Melih, additional, Kamisli, Caner, additional, Liu, Tao, additional, Maass, Alexander H., additional, Merse, Stefanie, additional, Morbach, Caroline, additional, Neumann, Anja, additional, Neumann, Till, additional, Sommer, Ilka, additional, Stoerk, Stefan, additional, Weingartz, Sarah, additional, Weiss, Anja, additional, and Wietasch, Goetz, additional

Published
2023
Full Text
View/download PDF

47. Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation

Author

Frausing, Maria Hee Jung Park, primary, Van De Lande, Martijn E, additional, Maass, Alexander H, additional, Nguyen, Bao-Oanh, additional, Hemels, Martin E W, additional, Tieleman, Robert G, additional, Koldenhof, Tim, additional, De Melis, Mirko, additional, Linz, Dominik, additional, Schotten, Ulrich, additional, Weberndörfer, Vanessa, additional, Crijns, Harry J G M, additional, Van Gelder, Isabelle C, additional, Nielsen, Jens Cosedis, additional, and Rienstra, Michiel, additional

Published
2023
Full Text
View/download PDF

48. Comparison of the relation of the ESC 2021 and ESC 2013 definitions of left bundle branch block with clinical and echocardiographic outcome in cardiac resynchronization therapy

Author

Rijks, Jesse, primary, Ghossein, Mohammed A., additional, Wouters, Philippe C., additional, Dural, Muhammet, additional, Maass, Alexander H., additional, Meine, Mathias, additional, Kloosterman, Mariëlle, additional, Luermans, Justin, additional, Prinzen, Frits W., additional, Vernooy, Kevin, additional, and van Stipdonk, Antonius M. W., additional

Published
2023
Full Text
View/download PDF

50. Electrocardiogram-based deep learning improves outcome prediction following cardiac resynchronization therapy

Author

Wouters, Philippe C, primary, van de Leur, Rutger R, additional, Vessies, Melle B, additional, van Stipdonk, Antonius M W, additional, Ghossein, Mohammed A, additional, Hassink, Rutger J, additional, Doevendans, Pieter A, additional, van der Harst, Pim, additional, Maass, Alexander H, additional, Prinzen, Frits W, additional, Vernooy, Kevin, additional, Meine, Mathias, additional, and van Es, René, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results